The contract development and manufacturing organization Rentschler Biopharma (Laupheim, Germany) has begun constructing a new facility in Milford, Massachusetts, next to an existing facility. The new 22,000-ft2 facility will boost the company’s cGMP manufacturing capacity and its ability to produce complex molecules for U.S.-based clients. Once completed, the facility will contain space for manufacturing, single-use…
Merck KGaA joins SaudiVax to develop halal vaccines and biotherapeutics
Merck KGaA, Darmstadt, Germany, will collaborate with Riyadh, Saudi Arabia-headquartered SaudiVax to design a manufacturing plant to produce biologics and vaccines for the Middle East and North Africa. Merck KGaA will also provide its integrated Contract Development Manufacturing Services as part of the partnership. SaudiVax intends to be the first Saudi company to manufacture halal…